These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 8457657

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products.
    Suzuki A, Ebinuma H, Matsuo M, Miyazaki O, Yago H.
    Thromb Res; 2007; 121(3):377-85. PubMed ID: 17561232
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evaluation of the fibrin binding profile of two anti-fibrin monoclonal antibodies.
    Raut S, Gaffney PJ.
    Thromb Haemost; 1996 Jul; 76(1):56-64. PubMed ID: 8819252
    [Abstract] [Full Text] [Related]

  • 6. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
    Stucki B, Schmutz P, Schmid L, Haeberli A, Lämmle B, Furlan M.
    Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005
    [Abstract] [Full Text] [Related]

  • 7. Characterization of a monoclonal antibody specific to the amino terminus of the alpha-chain of human fibrin.
    Mao SJ, Rechtin AE, Krstenansky JL, Jackson RL.
    Thromb Haemost; 1990 Jun 28; 63(3):445-8. PubMed ID: 2402748
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. "Fibrinogen Tokyo II". An abnormal fibrinogen with an impaired polymerization site on the aligned DD domain of fibrin molecules.
    Matsuda M, Baba M, Morimoto K, Nakamikawa C.
    J Clin Invest; 1983 Sep 28; 72(3):1034-41. PubMed ID: 6886002
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation of the factors contributing to fibrin-dependent plasminogen activation.
    Mosesson MW, Siebenlist KR, Voskuilen M, Nieuwenhuizen W.
    Thromb Haemost; 1998 Apr 28; 79(4):796-801. PubMed ID: 9569195
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Recombinant γT305A fibrinogen indicates severely impaired fibrin polymerization due to the aberrant function of hole 'A' and calcium binding sites.
    Ikeda M, Kobayashi T, Arai S, Mukai S, Takezawa Y, Terasawa F, Okumura N.
    Thromb Res; 2014 Aug 28; 134(2):518-25. PubMed ID: 24968960
    [Abstract] [Full Text] [Related]

  • 16. [Mechanism of the formation of complexes between monomer fibrin and the inhibitor of its polymerization - fragment D].
    Belitser VA, Pozdniakova TM, Vovk EV, Rybachuk VN.
    Biokhimiia; 1983 Jan 28; 48(1):125-31. PubMed ID: 6830911
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A new immunoassay for soluble fibrin enables a more sensitive detection of the activation state of blood coagulation in vivo.
    Lill H, Spannagl M, Trauner A, Schramm W, Schuller D, Ofenloch-Haehnle B, Draeger B, Naser W, Dessauer A.
    Blood Coagul Fibrinolysis; 1993 Feb 28; 4(1):97-102. PubMed ID: 8457660
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A novel monoclonal antibody to fibrin monomer and soluble fibrin for the detection of soluble fibrin in plasma.
    Hamano A, Tanaka S, Takeda Y, Umeda M, Sakata Y.
    Clin Chim Acta; 2002 Apr 28; 318(1-2):25-32. PubMed ID: 11880109
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.